223 related articles for article (PubMed ID: 27454673)
1. Human drug discrimination: A primer and methodological review.
Bolin BL; Alcorn JL; Reynolds AR; Lile JA; Rush CR
Exp Clin Psychopharmacol; 2016 Aug; 24(4):214-28. PubMed ID: 27454673
[TBL] [Abstract][Full Text] [Related]
2. Human Drug Discrimination: Elucidating the Neuropharmacology of Commonly Abused Illicit Drugs.
Bolin BL; Alcorn JL; Reynolds AR; Lile JA; Stoops WW; Rush CR
Curr Top Behav Neurosci; 2018; 39():261-295. PubMed ID: 27272070
[TBL] [Abstract][Full Text] [Related]
3. Hallucinogens in Drug Discrimination.
Baker LE
Curr Top Behav Neurosci; 2018; 36():201-219. PubMed ID: 28484970
[TBL] [Abstract][Full Text] [Related]
4. Drug discrimination by humans compared to nonhumans: current status and future directions.
Kamien JB; Bickel WK; Hughes JR; Higgins ST; Smith BJ
Psychopharmacology (Berl); 1993; 111(3):259-70. PubMed ID: 7870962
[TBL] [Abstract][Full Text] [Related]
5. Drug discrimination: A versatile tool for characterization of CNS safety pharmacology and potential for drug abuse.
Swedberg MD
J Pharmacol Toxicol Methods; 2016; 81():295-305. PubMed ID: 27235786
[TBL] [Abstract][Full Text] [Related]
6. Behavior analysis and experimental pharmacology.
Todorov JC
Neurosci Biobehav Rev; 1981; 5(3):307-14. PubMed ID: 7029359
[TBL] [Abstract][Full Text] [Related]
7. Drug discrimination in behavioral toxicology.
Colpaert FC
Zentralbl Bakteriol Mikrobiol Hyg B Umwelthyg Krankenhaushyg Arbeitshyg Prav Med; 1987 Oct; 185(1-2):48-51. PubMed ID: 3124387
[TBL] [Abstract][Full Text] [Related]
8. Clinical neuropharmacology of drugs of abuse: a comparison of drug-discrimination and subject-report measures.
Kelly TH; Stoops WW; Perry AS; Prendergast MA; Rush CR
Behav Cogn Neurosci Rev; 2003 Dec; 2(4):227-60. PubMed ID: 15006288
[TBL] [Abstract][Full Text] [Related]
9. Arylalkylamine drugs of abuse: an overview of drug discrimination studies.
Glennon RA
Pharmacol Biochem Behav; 1999 Oct; 64(2):251-6. PubMed ID: 10515299
[TBL] [Abstract][Full Text] [Related]
10. Investigating the pharmacological and nonpharmacological factors that modulate drug reinforcement.
Sigmon SC
Exp Clin Psychopharmacol; 2007 Feb; 15(1):1-20. PubMed ID: 17295581
[TBL] [Abstract][Full Text] [Related]
11. Use of cocaine-discrimination techniques for preclinical evaluation of candidate therapeutics for cocaine dependence.
Spealman RD
NIDA Res Monogr; 1992; 119():175-9. PubMed ID: 1435975
[No Abstract] [Full Text] [Related]
12. Behavior within fortuitous environments: The entwined history of Division 28 and the fields of behavioral pharmacology and toxicology.
Campbell ND
Exp Clin Psychopharmacol; 2016 Aug; 24(4):209-13. PubMed ID: 27454672
[TBL] [Abstract][Full Text] [Related]
13. Mu opioid mediated discriminative-stimulus effects of tramadol: an individual subjects analysis.
Strickland JC; Rush CR; Stoops WW
J Exp Anal Behav; 2015 Mar; 103(2):361-74. PubMed ID: 25664525
[TBL] [Abstract][Full Text] [Related]
14. Principles of drug abuse liability assessment in laboratory animals.
Ator NA; Griffiths RR
Drug Alcohol Depend; 2003 Jun; 70(3 Suppl):S55-72. PubMed ID: 12759197
[TBL] [Abstract][Full Text] [Related]
15. [Drug discrimination: methodology and current problems].
Watanabe S
Yakubutsu Seishin Kodo; 1985 Dec; 5(4):289-302. PubMed ID: 3914149
[TBL] [Abstract][Full Text] [Related]
16. Configurations of the interoceptive discriminative stimulus effects of ethanol and nicotine with two different exteroceptive contexts in rats: Extinction & recovery.
Troisi JR; Craig EM
Behav Processes; 2015 Jun; 115():169-80. PubMed ID: 25895858
[TBL] [Abstract][Full Text] [Related]
17. Current approaches and issues in non-clinical evaluation of abuse and dependence.
Moser P; Wolinsky T; Castagné V; Duxon M
J Pharmacol Toxicol Methods; 2011; 63(2):160-7. PubMed ID: 20868759
[TBL] [Abstract][Full Text] [Related]
18. We know very little about the subjective effects of drugs in females.
Bevins RA; Charntikov S
ACS Chem Neurosci; 2015 Mar; 6(3):359-61. PubMed ID: 25627010
[TBL] [Abstract][Full Text] [Related]
19. Drug discrimination methods in human drug abuse liability evaluation.
Preston KL
Br J Addict; 1991 Dec; 86(12):1587-94. PubMed ID: 1786491
[TBL] [Abstract][Full Text] [Related]
20. Drugs as chemical stimuli.
Balster RL
Psychopharmacol Ser; 1988; 4():1-11. PubMed ID: 3293037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
